Company type
Limited Corporation (APS)
Established
1993
Size
Medium
Employees
162
Revenue
187 MDKK
Gross profit
89 MDKK
Operating Profit (EBIT)
5,448,000 DKK
Profit for the year
6,500,000 DKK
Equity
35 MDKK
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!

Rank Profit for the year

Rank in industry
1/74
"Top 10%"
Rank in Denmark
18,018/322,119
"Top 10%"

Top management Top 3

Legal owners Top 3

100%Sonova AG

Rights certificate

Selskabet tegnes af to direktører i forening.

Company information based on CVR

NameSonova Audiological Care Denmark Aps
Alternate namesAudio Consult Slagelse Aps, Audiodan Høreklinik Aps, Audionova Aps, Audionova Hørecenter Aps, Auri Hørecenter Aps, Center for Bedre Hørelse Aps, Den Private Høreklinik Aps, Hørecenter Horsens Aps, Høreteknik, Vejle/Viby Aps, Næstved Hørecenter Aps, Sonova Retail Denmark Aps Show more
CVR16753181
AddressHans Edvard Teglers Vej 5, 1, 2920 Charlottenlund
IndustryRetail sale of medical and orthopaedic goods in specialized stores [477400]
Established01-01-1993 (29 yr)
Company typeLimited Corporation (APS)
Number of employees173 (man years:160)
Advertising protectionNo
AuditorEy Godkendt Revisionspartnerselskab since 30-06-2020
Financial statement period01-04 to 31-03
Company capital440,000 DKK
420,000 DKK (19-03-2020 - 27-03-2022)
400,000 DKK (10-02-2020 - 18-03-2020)
380,000 DKK (15-03-2019 - 09-02-2020)
360,000 DKK (29-01-2018 - 14-03-2019)
340,000 DKK (21-03-2017 - 28-01-2018)
Articles of assoc. last28-03-2022

Purpose

Selskabets formål er handel med, behandling af patienter med og undervisning vedrørende høreapparater, investering i andre selskaber, der driver virksomhed hermed samt anden i forbindelse hermed stående virksomhed.

Financial Statement

 202120202019
Currency/unit000' DKK000' DKK000' DKK
Revenue
186,586
-6%
198,743
+8%
184,496
+13%
Gross Profit
89,098
+13%
79,008
+16%
68,305
+11%
Profit for the year
6,500
-
-3,840
-
-17,774
-
Equity
35,129
+23%
28,629
+173%
10,469
+220%
Total Assets
105,169
0%
105,527
+3%
102,496
+23%

Mangement review

Management’s reviewFinancial highlights

Development in activities and financial mattersThe revenue for the year is DKK 186,586 thousand against DKK 198,743 thousand last year. The results after tax are DKK 6,500 thousand against DKK -3,840 thousand last year. The result is in line with the Managements expectation.In 2020/21 the Company has received DKK 7,354 thousand in Government grants related t compensation for the impact of Covid-19. This has been part of the relief for the Company. Although not fully in line with initial expectations due to impact of Covid-19 from mid March 2020, where our clinics were closed for approximately 2 months, the overall performance and results of our activities are considered to be satisfying. Successfully we have continued our value positioning focus and we have strengthened our internal balance in the dimensions of Employee engagement, Customer centricity and Business results further.Increased competition from local ear, nose and throat doctors has led to a decrease in the total private market. Furthermore main competitors are showing strong indications and actions to grow. Despite challenges in the market the Company has managed to protect and gain shares in the private market.StrategySonova Audiological Care Denmark ApS offers a complete range of digital hearing instruments, wireless FM systems and personal hearing protection.The development and manufacture of hearing instruments take place primarily in Stäfä, (Switzerland) where the Sonova Group has its headquarters and in Kitchener (Ontario, Canada), whereas wireless communication systems are manufactured in Murten (Switzerland).Product innovation, customer focus and cost management are the three pillars in the strategy.Financial risksOperating risksThe effects of fluctuations in the economy (expansion or recession) are expected to be limited for the Company, due to the fact that the dependency on the economic cycle is not very high. The Company acts in a healthcare market, where the dependency on the reimbursement system is large. Changes in legislation can lead to significant impact on the result of the Company.Financial risksThe Company holds sufficient liquidity to ensure the fulfillment of all planned payment obligations. The amount of the liquidity reserve is regularly reviewed and adjusted as necessary according to circumstances.Exchange rate risksThe Company is not significantly exposed to currency rate risks, since purchases take place in EUR and DKK while sales only take place in DKK. The Company does not hold any reserves in other currencies.Credit risksThe Company is not exposed to significant credit risks. The larger portion of the outstandings are Regions and/or Municipalities.
30-06-2021

Map